While the aggregation of amyloid β and the hyperphosphorylation of tau play well-established roles in the pathophysiology of Alzheimer’s disease (AD), the involvement of persistent neuroinflammation in the development and progression of this and other neurodegenerative disorders is increasingly accepted [1]. The gene discussed is MAPT; the disease is Alzheimer disease.